DRMANasdaqPharmaceutical PreparationsFiscal year ends December 31
Dermata Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$0.86−0.00 (-0.01%)
Close on Oct 19, 2026
- Market cap
- $3.46M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Aug 13, 2025(first seen in filings) | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Aug 1, 2025 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| May 16, 2024 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Mar 14, 2023 | 1-for-16 reverse | Earlier per-share figures multiplied by 16 |